Because even though ACE inhibitors increase overall kidney perfusion, they decrease glomerular perfusion. That's great in something like diabetic nephropathy where glomerular hypertension is accelerating the glomerulosclerosis - but it could be dangerous in something like bilateral renal artery stenosis, where the atII-constricted efferent arteriole is the only thing maintaining the glomerular pressure that is needed to maintain renal function.